Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseases
US9580501B2 · kind B2 · utility
4Cited by
23References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2012 |
| Grant date | Feb 28, 2017 |
| Priority date | — |
| Expiry date | Dec 14, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A monoclonal secretory IgA antibody, which binds to and neutralizes human TNFα. The secretory antibody is useful in treating a variety of inflammatory conditions in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.